| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |